BioCaptiva
Pre-clinicalmsX™ is a groundbreaking suite of polymers designed to unleash the full potential of liquid biopsy. Our patented polymers capture cfDNA directly from biological fluids without additional reagents, delivering enhanced cfDNA yields with exceptional sample stability and minimal pre-analytical processing. msX™ offers new, game-changing possibilities for non-invasive genetic testing and personalised medicine.
About
msX™ is a groundbreaking suite of polymers designed to unleash the full potential of liquid biopsy. Our patented polymers capture cfDNA directly from biological fluids without additional reagents, delivering enhanced cfDNA yields with exceptional sample stability and minimal pre-analytical processing. msX™ offers new, game-changing possibilities for non-invasive genetic testing and personalised medicine.
Funding History
2Total raised: $4.8M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile